Filing Flows › Edwards Lifesciences (EW) › Surgical revenue
Edwards Lifesciences (EW) Surgical revenue by quarter
Edwards Lifesciences' Surgical revenue was $264M in Q3 2026 (third quarter 2026), -7% from Q2 2026. Over the last 3 quarters it ranged from $264M (Q3 2026) to $284M (Q2 2026).
| Quarter | Surgical revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $264M | -7% | — |
| Q2 2026 | $284M | +3% | — |
| Q1 2026 | $276M | — | — |
Q3 2026 at a glance
Edwards Lifesciences, Q3 2026: revenue $1.7B (+10% year over year), operating margin 17.4%, net earnings $308M, operating cash flow $570M. The chart follows the revenue to costs, profit and cash.
Questions
What is Edwards Lifesciences' Surgical revenue?
Edwards Lifesciences' Surgical revenue was $264M in Q3 2026 (third quarter 2026), -7% from Q2 2026.
How has Edwards Lifesciences' Surgical revenue changed?
Over the last 3 quarters it ranged from $264M (Q3 2026) to $284M (Q2 2026).